The Plight of Postdocs

Michael Cowan Many consider postdoctoral fellows the sinew of American science; they enable forward motion and new discoveries as science flexes its muscle. "Since the 1960s, the performance of research in the United States has relied more and more on graduate scientists and engineers who have recently earned a Ph.D. and are pursuing further education and training," asserts a recently published report on postdocs by the Committee on Science Engineering and Public Policy (COSEPUP) of the National

Written byHarvey Black
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Michael Cowan
Many consider postdoctoral fellows the sinew of American science; they enable forward motion and new discoveries as science flexes its muscle. "Since the 1960s, the performance of research in the United States has relied more and more on graduate scientists and engineers who have recently earned a Ph.D. and are pursuing further education and training," asserts a recently published report on postdocs by the Committee on Science Engineering and Public Policy (COSEPUP) of the National Academy of Sciences.1 Michael Cowan, recently appointed associate dean for postdoctoral affairs at Stanford University puts it more directly: "They are producing the results that really drive the discovery of new knowledge. They're incredibly important to the nation."

Postdocs do not, how- ever, always feel their treatment matches the weight of those words. According to Pauline Wong, a postdoc in the department of biological chemistry at Johns Hopkins School of Medicine, being a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies